APIs (active pharmaceutical ingredients)

(Image: Getty/Rzarek)

Darmerica recalls API lots due to label mix-up

By Vassia Barba

Darmerica recalls two lots of product labeled as quinacrine, a compound used as a sclerosing agent, which were instead found to contain a treatment for malaria.

(Image: Getty/AndreyPopov)

Mundipharma bets $568m on antifungal treatment

By Ben Hargreaves

Mundipharma signs agreement to progress an antifungal candidate through to commercialization, with the potential for it to become the first approved treatment in 13 years.